p-Coumaric acid inhibits indoleamine 2, 3-dioxygenase expression in murine dendritic cells

International Immunopharmacology

Volumn 7, Issue 6, 2007, Pages 805-815

  Kim, Sang Il ^a   Jeong, Young Il ^b   Jung, In Duk ^c   Lee, Jun Sik ^b   Lee, Chang Min ^c   Yoon, Man Soo ^a   Seong, Eun Young ^b   Kim, Jong Il ^b   Lee, Jae Dong ^b   Park, Yeong Min ^c  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c National Research Laboratory of Dendritic Cell Differentiation and Regulation   (South Korea)

Author keywords

IDO; IFN ; Murine BMDCs; PKR; STAT1

Indexed keywords

CD8ALPHA ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INDOLEAMINE 2,3 DIOXYGENASE; PARA COUMARIC ACID; PROTEIN SERINE THREONINE KINASE; STAT1 PROTEIN; TRYPTOPHAN;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; CATALYSIS; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COUMARIC ACIDS; DENDRITIC CELLS; IMMUNOLOGIC FACTORS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; LYMPH NODES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 34247468980     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.01.020     Document Type: Article

References (51)

1. Granucci F., Zanoni I., Feau S., and Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 22 11 (2003) 2546-2551
2. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9 (1991) 271-296
3. Austyn J.M., Kupiec-Weglinski J.W., Hankins D.F., and Morris P.J. Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med 167 2 (1988) 646-651
4. Rock K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 17 3 (1996) 131-137
5. Grohmann U., Bianchi R., Belladonna M.L., Silla S., Fallarino F., Fioretti M.C., et al. IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha-dendritic cells via potentiation of the CD8 alpha+ subset. J Immunol 165 3 (2000) 1357-1363
6. Mellor A.L., and Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol Today 20 10 (1999) 469-473
7. Ozaki Y., Edelstein M.P., and Duch D.S. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci U S A 85 4 (1988) 1242-1246
8. Sakurai K., Zou J.P., Tschetter J.R., Ward J.M., and Shearer G.M. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129 1-2 (2002) 186-196
9. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., and Young H.A. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164 7 (2000) 3596-3599
10. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., and Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189 9 (1999) 1363-1372
11. Grohmann U., Fallarino F., Bianchi R., Belladonna M.L., Vacca C., Orabona C., et al. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol 167 2 (2001) 708-714
12. Grohmann U., Fallarino F., Silla S., Bianchi R., Belladonna M.L., Vacca C., et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J Immunol 166 1 (2001) 277-283
13. Takikawa O., Habara-Ohkubo A., and Yoshida R. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J Immunol 145 4 (1990) 1246-1250
14. Burke F., Knowles R.G., East N., and Balkwill F.R. The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo. Int J Cancer 60 1 (1995) 115-122
15. Taylor M.W., and Feng G.S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5 11 (1991) 2516-2522
16. Varga J., Yufit T., Hitraya E., and Brown R.R. Control of extracellular matrix degradation by interferon-gamma. The tryptophan connection. Adv Exp Med Biol 398 (1996) 143-148
17. Blair L.A., Maggi Jr. L.B., Scarim A.L., and Corbett J.A. Role of interferon regulatory factor-1 in double-stranded RNA-induced iNOS expression by mouse islets. J Biol Chem 277 1 (2002) 359-365
18. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4 10 (2004) 762-774
19. Castelluccio C., Paganga G., Melikian N., Bolwell G.P., Pridham J., Sampson J., et al. Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS Lett 368 1 (1995) 188-192
20. Castelluccio C., Bolwell G.P., Gerrish C., and Rice-Evans C. Differential distribution of ferulic acid to the major plasma constituents in relation to its potential as an antioxidant. Biochem J 316 Pt 2 (1996) 691-694
21. Laranjinha J., Vieira O., Madeira V., and Almeida L. Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration. Arch Biochem Biophys 323 2 (1995) 373-381
22. Laranjinha J., Vierira O., Almeida L., and Madeira V. Inhibition of metmyoglobin/H2O2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem Pharmacol 51 4 (1996) 395-402
23. Loake G.J., Faktor O., Lamb C.J., and Dixon R.A. Combination of H-box [CCTACC(N)7CT] and G-box (CACGTG) cis elements is necessary for feed-forward stimulation of a chalcone synthase promoter by the phenylpropanoid-pathway intermediate p-coumaric acid. Proc Natl Acad Sci U S A 89 19 (1992) 9230-9234
24. Zang L.Y., Cosma G., Gardner H., Shi X., Castranova V., Vallyathan V., et al. Effect of antioxidant protection by p-coumaric acid on low-density lipoprotein cholesterol oxidation. Am J Physiol Cell Physiol 279 4 (2000) C954-C960
25. Thomas S.R., Salahifar H., Mashima R., Hunt N.H., Richardson D.R., and Stocker R. Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol 166 10 (2001) 6332-6340
26. Chowdhury M., Kabir S.N., Pal A.K., and Pakrashi A. Modulation of luteinizing hormone receptors: effect of an inhibitor of prolactin secretion, p-coumaric acid. J Endocrinol 98 3 (1983) 307-311
27. Gerlo S., Verdood P., Hooghe-Peters E.L., and Kooijman R. Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells. Cell Mol Life Sci 63 1 (2006) 92-99
28. Montgomery D.W. Prolactin production by immune cells. Lupus 10 10 (2001) 665-675
29. Yang L., Hu Y., Li X., Zhao J., and Hou Y. Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells. Int Immunopharmacol 6 9 (2006) 1478-1486
30. Kawaguchi R., Ozawa-Kondo M., Ohta-Misaki I., Suzuki-Karasaki M., Hayakawa S., Yamamoto T., et al. Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells. Nihon Rinsho Meneki Gakkai Kaishi 28 6 (2005) 407-412
31. Carreno P.C., Jimenez E., Sacedon R., Vicente A., and Zapata A.G. Prolactin stimulates maturation and function of rat thymic dendritic cells. J Neuroimmunol 153 1-2 (2004) 83-90
32. Freeman M.E., Kanyicska B., Lerant A., and Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 80 4 (2000) 1523-1631
33. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 6 (1992) 1693-1702
34. Porgador A., and Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182 1 (1995) 255-260
35. Langenkamp A., Messi M., Lanzavecchia A., and Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 1 4 (2000) 311-316
36. Beutelspacher S.C., Pillai R., Watson M.P., Tan P.H., Tsang J., McClure M.O., et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 36 3 (2006) 690-700
37. Chon S.Y., Hassanain H.H., and Gupta S.L. Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene. J Biol Chem 271 29 (1996) 17247-17252
38. Hu X., Herrero C., Li W.P., Antoniv T.T., Falck-Pedersen E., Koch A.E., et al. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol 3 9 (2002) 859-866
39. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 3 (1996) 431-442
40. Ahn S.C., Kim G.Y., Kim J.H., Baik S.W., Han M.K., Lee H.J., et al. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem Biophys Res Commun 313 1 (2004) 148-155
41. Kim G.Y., Cho H., Ahn S.C., Oh Y.H., Lee C.M., and Park Y.M. Resveratrol inhibits phenotypic and functional maturation of murine bone marrow-derived dendritic cells. Int Immunopharmacol 4 2 (2004) 245-253
42. Kim G.Y., Kim J.H., Ahn S.C., Lee H.J., Moon D.O., Lee C.M., et al. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology 113 2 (2004) 203-211
43. Kim G.Y., Kim K.H., Lee S.H., Yoon M.S., Lee H.J., Moon D.O., et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174 12 (2005) 8116-8124
44. Kim G.Y., Lee M.Y., Lee H.J., Moon D.O., Lee C.M., Jin C.Y., et al. Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. Int Immunopharmacol 5 10 (2005) 1523-1532
45. Kim G.Y., Oh W.K., Shin B.C., Shin Y.I., Park Y.C., Ahn S.C., et al. Proteoglycan isolated from Phellinus linteus inhibits tumor growth through mechanisms leading to an activation of CD11c+CD8+ DC and type I helper T cell-dominant immune state. FEBS Lett 576 3 (2004) 391-400
46. Matera L., Mori M., and Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 10 10 (2001) 728-734
47. Munn D.H., Sharma M.D., Hou D., Baban B., Lee J.R., Antonia S.J., et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114 2 (2004) 280-290
48. Grohmann U., Fallarino F., Bianchi R., Orabona C., Vacca C., Fioretti M.C., et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 198 1 (2003) 153-160
49. Suzuki S., Tone S., Takikawa O., Kubo T., Kohno I., and Minatogawa Y. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J 355 Pt 2 (2001) 425-429
50. Du M.X., Sotero-Esteva W.D., and Taylor M.W. Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma. J Interferon Cytokine Res 20 2 (2000) 133-142
51. Kumar A., Yang Y.L., Flati V., Der S., Kadereit S., Deb A., et al. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. Embo J 16 2 (1997) 406-416